Analyst Ratings For NASDAQ:CELG – Celgene (NASDAQ:CELG)
Today, Morgan Stanley reiterated its Equal rating on NASDAQ:CELG – Celgene (NASDAQ:CELG) with a price target of $93.00.
Some recent analyst ratings include
- 4/13/2018-Morgan Stanley Reiterated Rating of Equal .
- 3/21/2018-JPMorgan Chase initiated coverage with a Overweight rating.
- 3/1/2018-Robert W. Baird Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:CELG – Celgene (NASDAQ:CELG)
NASDAQ:CELG – Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 78.63%.
- On 3/12/2018 James J Loughlin, Director, sold 9,250 with an average share price of $92.01 per share and the total transaction amounting to $851,092.50.
- On 2/23/2018 Ernest Mario, Director, sold 13,370 with an average share price of $94.49 per share and the total transaction amounting to $1,263,331.30.
- On 2/20/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $94.83 per share and the total transaction amounting to $877,177.50.
- On 2/15/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $95.99 per share and the total transaction amounting to $887,907.50.
- On 2/8/2018 Mark J Alles, Insider, bought 3,260 with an average share price of $91.90 per share and the total transaction amounting to $299,594.00.
- On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
- On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.
Recent Trading Activity for NASDAQ:CELG – Celgene (NASDAQ:CELG)
Shares of NASDAQ:CELG – Celgene closed the previous trading session at 89.78 up +0.04 0.04% with 90.98999786376953 shares trading hands.